LGC, Biosearch Technologies proudly introduces RapiDxFire™ Thermostable RT, a truly thermostable reverse transcriptase (RT) designed specifically to meet the needs of diagnostic kit developers.
This reverse transcriptase has a temperature optimum from 55 – 80 °C, improving reaction specificity and allowing synthesis from diverse RNA templates. It is also fast, with a reaction time of five minutes or less, and recommended for targets under 1 kb. Its extended stability at room temperature provides automation deck compatibility, and the enzyme is available in a lyophilization-ready, Triton™ X-100 free format.
Mark Dearden, VP Strategy and Marketing, LGC, Biosearch Technologies, said, “LGC has a tremendous business partnering with the world’s leading Molecular Diagnostic kit developers. The launch of our new RapiDxFire™ Thermostable RT extends our capabilities for these partners, delivering a novel enzyme that have superior specificity, speed, and room temperature stability. It’s a great example of how LGC continues to deliver on its strategy to be a leading provider of mission critical tools that enable molecular diagnostic development.”